Company / Capital Returned to Shareholders
Insulet Corporation Capital Returned to Shareholders History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$59.6M
FY2025
5-year range
$0 / $59.6M
FY2023-FY2025
Trend
-
vs FY2024
Sector context
#62 of 103
Health Care
What the data says
At $60M, Insulet Corporation's capital returned to shareholders ranks #62 of 103 in the Health Care sector. Improved from $0 to $60M over the past 2 years.
Based on SEC 10-K filings.
$60M in FY2025.
Improved from $0 to $60M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#62 of 103 in Health CareTop 60% of 103This company $59.6M Sector average $721.8M
▼
-91.7% below sector average
Key checks
Key Insights
- Ranks #62 out of 103 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $59.6M | - |
| FY2024 | $0 | - |
| FY2023 | $0 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026